Taís Kereski da Silva1, Marina Carvalho Berbigier1, Bibiana de Almeida Rubin2, Rafael Barberena Moraes3, Gabriela Corrêa Souza4, Ingrid Dalira Schweigert Perry5. 1. Multiprofessional Integrated Residency Program in Health, with emphasis on Critical Adults, Hospital de Clínicas de Porto Alegre, Brazil Food and Nutrition Research Center, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil. 2. Food and Nutrition Research Center, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil Nutrition and Dietetics Service, Hospital de Clínicas de Porto Alegre, Brazil. 3. Intensive Medicine Service, Hospital de Clínicas de Porto Alegre, Brazil. 4. Food and Nutrition Research Center, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil Intensive Medicine Department, School of Medicine, Universidade Federal do Rio Grande do Sul, Brazil. 5. Food and Nutrition Research Center, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil Health Unit, Universidade do Extremo Sul Catarinense, Criciúma, Brazil atputp@gmail.com.
Abstract
BACKGROUND: Phase angle (PA) is interpreted as an indicator of cell membrane integrity and a prognostic indicator in some clinical situations. This study aims to evaluate PA as a prognostic marker in critically ill patients admitted to the intensive care unit (ICU) and associate this marker with length of hospital stay, mortality, and clinical scores. METHODS: A cohort study was conducted with 95 patients aged ≥18 years admitted to the ICU, who were assessed in terms of prognostic indexes (Acute Physiology and Chronic Health Evaluation II [APACHE II] and Sequential Organ Failure Assessment [SOFA]), clinical evolution (ICU discharge, death, and length of ICU stay), and PA. RESULTS: Patients were predominantly male (63.1%) and had a mean age of 63.7 ± 14.6 years; length of stay of 4 days (range, 3-9 days); mortality of 15.8%; mean APACHE II and SOFA scores of 17.3 ± 8.2 and 6.1 ± 3.1 points, respectively; and mean PA of 4.91 ± 1.36°. An association was observed between females and PA <5.1° (P = .035), which was the cutoff point determined from the receiver operating characteristic curve. PA was correlated with APACHE II score (r = -0.241; P = .02). This correlation became moderate only when patients without sepsis were considered (r = -0.506; P < .001). CONCLUSIONS: PA seems to be a good prognostic marker for patients without sepsis. The weak correlation between PA and APACHE II score and the lack of association with other clinical outcomes are limitations for interpreting the prognostic value of PA in the entire study sample.
BACKGROUND: Phase angle (PA) is interpreted as an indicator of cell membrane integrity and a prognostic indicator in some clinical situations. This study aims to evaluate PA as a prognostic marker in critically illpatients admitted to the intensive care unit (ICU) and associate this marker with length of hospital stay, mortality, and clinical scores. METHODS: A cohort study was conducted with 95 patients aged ≥18 years admitted to the ICU, who were assessed in terms of prognostic indexes (Acute Physiology and Chronic Health Evaluation II [APACHE II] and Sequential Organ Failure Assessment [SOFA]), clinical evolution (ICU discharge, death, and length of ICU stay), and PA. RESULTS:Patients were predominantly male (63.1%) and had a mean age of 63.7 ± 14.6 years; length of stay of 4 days (range, 3-9 days); mortality of 15.8%; mean APACHE II and SOFA scores of 17.3 ± 8.2 and 6.1 ± 3.1 points, respectively; and mean PA of 4.91 ± 1.36°. An association was observed between females and PA <5.1° (P = .035), which was the cutoff point determined from the receiver operating characteristic curve. PA was correlated with APACHE II score (r = -0.241; P = .02). This correlation became moderate only when patients without sepsis were considered (r = -0.506; P < .001). CONCLUSIONS:PA seems to be a good prognostic marker for patients without sepsis. The weak correlation between PA and APACHE II score and the lack of association with other clinical outcomes are limitations for interpreting the prognostic value of PA in the entire study sample.
Authors: L Nescolarde; H Lukaski; A De Lorenzo; B de-Mateo-Silleras; M P Redondo-Del-Río; M A Camina-Martín Journal: Eur J Clin Nutr Date: 2016-07-06 Impact factor: 4.016
Authors: Emanuele Rinninella; Marco Cintoni; Antonino De Lorenzo; Giovanni Addolorato; Gabriele Vassallo; Rossana Moroni; Giacinto Abele Donato Miggiano; Antonio Gasbarrini; Maria Cristina Mele Journal: Intern Emerg Med Date: 2018-05-30 Impact factor: 3.397
Authors: Nicolaas E P Deutz; Pierre Singer; Raven A Wierzchowska-McNew; Marina V Viana; Itai A Ben-David; Olivier Pantet; John J Thaden; Gabriella A M Ten Have; Mariëlle P K J Engelen; Mette M Berger Journal: Clin Nutr Date: 2021-03-18 Impact factor: 7.324
Authors: Giliane Belarmino; Maria Cristina Gonzalez; Raquel S Torrinhas; Priscila Sala; Wellington Andraus; Luiz Augusto Carneiro D'Albuquerque; Rosa Maria R Pereira; Valéria F Caparbo; Graziela R Ravacci; Lucas Damiani; Steven B Heymsfield; Dan L Waitzberg Journal: World J Hepatol Date: 2017-03-08
Authors: Karina M Vermeulen; Márcia M G D Lopes; Evellyn C Grilo; Camila X Alves; Richele J A Machado; Lucia L Lais; José Brandão-Neto; Sancha H L Vale Journal: Food Nutr Res Date: 2019-04-10 Impact factor: 3.894
Authors: Sandra N Stapel; Wilhelmus G P M Looijaard; Ingeborg M Dekker; Armand R J Girbes; Peter J M Weijs; Heleen M Oudemans-van Straaten Journal: Eur J Clin Nutr Date: 2018-05-11 Impact factor: 4.016